FDA Adverse Event
Malfunction
Summary report: N
NEULASTA OBI
MDR report key: 12786274
·
Received November 10, 2021
Report
- Report Number
- 12786274
- Event Type
- Malfunction
- Date Received
- November 10, 2021
- Date of Event
- July 20, 2021
- Report Date
- November 9, 2021
- Manufacturer
- AMGEN INC.
- Product Code
- KZH
- Product Problem
- Yes
- Report Source
- User Facility report
- Reporter Location
- ME
- Reporter Occupation
- OTHER HEALTH CARE PROFESSIONAL
- Health Professional
- Yes
Narratives
Description of Event or Problem · 0
NARRATIVE FROM STAFF: PATIENT HAD QUESTIONABLE INJECTION OF NEULASTA OBI ON CYCLE #1 OF CHEMO. PATIENT CALLED IN AND REPORTED FAILURE OF DEVICE. UNCLEAR IF IT WAS ADDRESSED BY COVERING PROVIDER. PATIENT WAS SUBSEQUENTLY ADMITTED FOR SEPSIS AND HAD SUBSEQUENT CYCLES OF CHEMOTHERAPY DOSE REDUCED. OUR TEAM WAS INFORMED OF THIS EVENT LAST WEEK.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 1687851 | NEULASTA OBI | INTRODUCER, SYRINGE NEEDLE | KZH | AMGEN INC. | 1131930D |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | 27740 DA | Female |